Search Results - "Rozalen, Alexandra Zara"
-
1
Ductal Adenocarcinoma of the Prostate with Novel Genetic Alterations Characterized by Next-Generation Sequencing
Published in Current oncology (Toronto) (01-03-2024)“…Ductal adenocarcinoma of the prostate (DAP) is an uncommon variant of prostate cancer associated with aggressive disease and poor outcome. It presents most…”
Get full text
Journal Article -
2
Androgen receptor amplification in mesonephric remnants
Published in BMJ case reports (09-06-2023)“…Mesonephric remnants (MRs) are embryonic vestiges most commonly found in female pathology specimens from the lateral wall of the cervix. The highly regulated…”
Get more information
Journal Article -
3
Mott Cells: A Diagnostic Clue for IgG4-Positive Extranodal Marginal Zone Lymphoma
Published in Archives of pathology & laboratory medicine (1976) (01-09-2024)Get full text
Journal Article -
4
X-linked inhibitor of apoptosis protein (XIAP) expression level analyzed by immunohistochemistry (IHC) as it relates to clinical and pathologic characteristics in prostate cancer
Published in Journal of clinical oncology (01-06-2023)“…e17012 Background: XIAP acts in both the extrinsic and intrinsic apoptotic pathways as an inhibitor of cell death, protecting cells from a range of triggers…”
Get full text
Journal Article -
5
Assessing the discordance rate of HER2 expression by immunohistochemistry between primary and secondary prostate cancer biopsies
Published in Journal of clinical oncology (01-06-2023)“…e17014 Background: Preliminary evidence suggests that human epidermal growth factor receptor 2 (HER2) expression may play a role in tumor cell proliferation in…”
Get full text
Journal Article -
6
The prevalence and clinical significance of HER2 overexpression in prostate adenocarcinoma
Published in Journal of clinical oncology (20-02-2023)“…212 Background: The HER2 oncogene serves as a prognostic marker in breast cancer and is a therapeutic target in breast, lung, and GI malignancies, including…”
Get full text
Journal Article -
7
The prevalence and clinical significance of HER2 expression in prostate adenocarcinoma
Published in Annals of diagnostic pathology (01-12-2023)“…Abnormalities in HER2 are well-established oncogenic drivers and are approved therapeutic targets in various malignancies. Prior studies evaluating HER2…”
Get full text
Journal Article -
8
Tumeur atypique multifocale a cellules granuleuses avec altération somatique FLT3 Y842C: Un rapport de cas et revue de la littérature
Published in Tunisie Medicale (01-10-2024)“…Introduction: Les tumeurs à cellules granuleuses (TCG) sont des tumeurs principalement bénignes ca- ractérisées par des cellules avec un cytoplasme granulaire…”
Get full text
Journal Article -
9
Atypical Multifocal Granular Cell Tumor with FLT3 Y842C Somatic Mutation: A case report and a review of the literature
Published in La Tunisie medicale (05-10-2024)“…Granular cell tumors (GCT) are predominantly benign neoplasms composed by cells with abundant eosinophilic granular cytoplasm. Although the majority of GCTs…”
Get more information
Journal Article -
10
Ductal Adenocarcinoma of the Prostate with Novel Genetic Alterations Characterized by Next-Generation Sequencing
Published in Current oncology (Toronto, Ont.) (19-03-2024)“…Ductal adenocarcinoma of the prostate (DAP) is an uncommon variant of prostate cancer associated with aggressive disease and poor outcome. It presents most…”
Get full text
Report